Striatal Blood–Brain Barrier Permeability in Parkinson'S Disease

Gray, Madison T, Woulfe, John M·2015·Journal of Cerebral Blood Flow & Metabolism
DOI 10.1038/jcbfm.2015.32

Cited by (409)

Items 301–400 of 409

  1. Human pericytes degrade α-synuclein aggregates in a strain-dependent manner
    Birger Victor Dieriks, Blake Highet, Ania Alik, Tracy Bellande, Taylor J. Stevenson, Victoria F. Low, Thomas Park, Jason A. Correia, Patrick M. Schweder, Richard L. M. Faull et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  2. LRRK2 G2019S Mutated iPSC-Derived Endothelial Cells Exhibit Increased α-Synuclein, Mitochondrial Impairment, and Altered Inflammatory Responses
    Tuuli-Maria Sonninen, Sanni Peltonen, Jonna Niskanen, Riikka H. Hämäläinen, Jari Koıstınaho, Šárka Lehtonen · 2024 · International Journal of Molecular Sciences
  3. Perspective on Cav-1 for its Potential as Newer Therapeutics for Parkinson’s Disease
    Gurpreet Singh, T Pushpa, Sunil Gupta, Saurabh Srivastava, Dharmendra Kumar Khatri, Shashi Bala Singh · 2022 · CNS & Neurological Disorders - Drug Targets
  4. EEG markers of attention sustainability detected in neuropsychological testing in different age groups
    Vladimir Yu. Ulyanov, Maksim О. Zhuravlev, Anton R. Kiselev, V. Yu. Musatov, Tatiyana Musatova, Н. С. Акимова, Ruzanna R. Parsamyan, Руннова Анастасия Евгеньевна · 2023 · The European Physical Journal Special Topics
  5. Postencephalitic Parkinsonism: Unique Pathological and Clinical Features—Preliminary Data
    Sabrina Strobel, Jeswinder Sian‐Hülsmann, Dennis Tappe, K. A. Jellinger, Peter Franz Riederer, Camelia‐Maria Monoranu · 2024 · Cells
  6. Nanoparticle Interactions with the Blood Brain Barrier: Insights from Drosophila and Implications for Human Astrocyte Targeted Therapies
    Akshata Choudhari Padti, Santosh Mallikarjun Bhavi, Bothe Thokchom, Sapam Riches Singh, Shivanand S. Bhat, Ballagere Puttaraju Harini, Mika E. T. Sillanpää, Ramesh Babu Yarajarla · 2025 · Neurochemical Research
  7. Report on the Myomatrix Conference April 22–24, 2012, University of Nevada, Reno, Nevada, USA
    Anne Rutkowski, Carsten G. Bönnemann, S. Brown, Sólveig Þorsteinsdóttir, Janice A. Dominov, Markus A. Rüegg, Michelle L. Matter, Denis C. Guttridge, Rachelle H. Crosbie, Gabrielle Kardon et al. · 2012 · Neuromuscular Disorders
  8. Mutated LRRK2 induces a reactive phenotype and alters migration in human iPSC-derived pericyte-like cells
    Sanni Peltonen, Tuuli-Maria Sonninen, Jonna Niskanen, Jari Koıstınaho, Marika Ruponen, Šárka Lehtonen · 2024 · Fluids and Barriers of the CNS
  9. Expression of genes for neurotransmitter transporters in astrocytes in different brain regions in experiment
    Natalia Nikolaevna Shusharina, Maxim V. Patrushev, Ekaterina Vladimirovna Silina, Victor Aleksandrovich Stupin, Peter F. Litvitskiy, Aleksandra Sergeevna Orlova · 2018 · S S Korsakov Journal of Neurology and Psychiatry
  10. Regulation of the Blood–Brain Barrier in Health and Disease
    Cara Coleen Rada, Kanako Yuki, Jie Ding, Calvin Jay Kuo · 2023 · Cold Spring Harbor Perspectives in Medicine
  11. Hemodynamic subtype profiling in tremor-dominant and akinetic–rigid Parkinson’s disease using multi-delay pseudo-continuous arterial spin labeling imaging
    Yu Pan, Zhaoxia Qin, Jiangbing Liu, Wei Wang, Yi Zhao · 2025 · Frontiers in Human Neuroscience
  12. Elevated plasma levels of alpha-synuclein are dispensable for Parkinson’s disease pathology
    Jin-Young Jeong, Namsuk Kim, Yan Li, Doo‐Jin Kim, Hyong Kyu Kim, Won‐Jong Oh · 2025 · npj Parkinson s Disease
  13. Neuroprotective effects of hypoactive Akkermansia muciniphila in MPTP-induced mouse models of Parkinson’s disease
    Jiahui Xi, Chengcheng Tang, Xian Xiao, Min Chen, Qingjian Zou, Xiaoqing Zhou · 2025 · Microbiology Spectrum
  14. Intranasally administered muse cells attenuate neurodegeneration in Parkinson’s disease
    Zhe Lu, Shifeng Ren, Bingjie Wang, Liwei Shao, Yajun Zhang, Haomeng Wu, Xiaodong Mu, Zhihui Wang · 2025 · Journal of Translational Medicine
  15. Niosome-encapsulated sodium butyrate enhances blood-brain barrier integrity and reduces neuroinflammation in a rat model of ischemic stroke
    Nasim Naseri, Mohammad Reza Bigdeli, F Attarbashi Moghadam, Bahram Kazemi · 2026 · Brain Research Bulletin
  16. Nanomedicine for neuroinflammation modulation: Next-generation nano-immunotherapies for neurodegenerative disorders
    Irra Dhar, Sunidhi Bhatt, Swati Gupta, Sujeet Kumar Singh, Abhishek Dadhich · 2026 · Next Nanotechnology
  17. Nano-carriers for brain disorders targeting the blood brain barrier (BBB) crossing strategies
    Krishna Radheshyam Gupta, Shalaka Dabhekar, Madhura Dixit, Milind Janrao Umekar · 2021 · Indian Journal of Pharmacy and Pharmacology
  18. Multimodal Imaging of Blood–Brain Barrier Dysfunction in Parkinson's Disease: From Pathological Mechanisms to Therapeutic Opportunities
    Zhihong Lu, Haolin Yin, Pan Xiang, Xuan Yi, Xiaohe Tian, Qiyong Gong · 2025 · European Journal of Neuroscience
  19. Polyphenols as Potential Therapeutic Drugs in Neurodegeneration
    Patrizia Polverino de Laureto, Luana Palazzi, Laura Acquasaliente · 2019 · IntechOpen eBooks
  20. Повреждение гематоэнцефалического барьера при стрессе и нейродегенерации: биохимические механизмы и новые модели для трансляционных исследований
    Alla B. Salmina, Ю К Комлева, Наталия Александровна Малиновская, Andrey V. Morgun, Елена Анатольевна Тепляшина, Olga L. Lopatina, Yana V. Gorina, Ekaterina Viktorovna Kharitonova, Е. Д. Хилажева, Аnton N. Shuvaev · 2021 · Biochemistry (Moscow)
  21. [Use of sodium diclofenac in acute renal colic].
    A Tankó, G Tamás · 1996 · PubMed
  22. Review article: the role of epigenetics as an underlying regulator of the immune responses in Parkinson’s disease
    Maria Georgoula, Panagiotis Ntavaroukas, Barry James Campbell, Stamatia Papoutsopoulou · 2024 · Epigenetics Reports
  23. Effect of electroacupuncture on the MMP-2/9 pathway mediated blood-brain barrier permeability in mice with Parkinson's disease
    Xiaolei Zhang, Min Hu, Yanan Li, Yao WANG, Zhen RONG, Jun Ma · 2025 · 世界针灸杂志：英文版
  24. Effects of astrocytes in the dorsal hippocampus on anxiety-like and depressive-like behaviors in hemiparkinsonian rats
    Yi-Wei Hu, Jian Liu, Zi-Han Qiu, Xiao-Ying Li, Juan Li, Li Chen, Tao Wang, Xin-Feng Wang, Zhong-Jie Feng, Wan-Ting Bai et al. · 2025 · Behavioural Brain Research
  25. Material considerations for delivering therapeutics across the blood–brain barrier
    Ava N. Zoba, Christina M. Tringides · 2025 · APL Materials
  26. miR126-mediated alteration of vascular integrity in Rett syndrome
    Tatsuya Osaki, Zhengpeng Wan, Koji Haratani, Ylliah Jin, M. Campisi, D. Barbie, R. Kamm, M. Sur · 2026 · Molecular Psychiatry
  27. Neurovascular Unit Dysfunction and Cerebral Small Vessel Disease in Parkinson Disease
    Dylan Del Papa, Jessica Herman, Aidan Theepura Kunju, Tara Najafi, Ryan P. O’Boyle, Adam Salama, Layal Hneiny, Thilani Samarakoon, Taylor K. Peabody, Sarah Marmol et al. · 2026 · Neurology
  28. Profiling peripheral immune cells in Parkinson's disease: A scoping review
    Sherilyn Junelle Recinto, Janna E. Jernigan, Nadejda Lefter, Zagorka Vitic, Morten Ogelund Overgaard, Lin Liu, Andrew J.M. Howden, Klaus Eyer, Marina Romero‐Ramos, Malú G. Tansey et al. · 2026 · Journal of Parkinson s Disease
  29. Parkinsonian Patients Requiring Proteasome Inhibitors for Multiple Myeloma: Exceptional Circumstances Call for Extra Caution
    Pierre Rocanières, Sylvain Lamure, Christian Gény, Dominique Hillaire‐Buys, Jean‐Luc Faillie, Virginie Brès · 2022 · Journal of Parkinson s Disease
  30. Central nervous system diseases associated with blood brain barrier breakdown - A Comprehensive update of existing literature
    Rajib Dutta · 2020 · Journal of Neuroscience and Neurological Disorders
  31. Parkinson's disease: A chronic systemic inflammatory disorder
    Hina Khan, Matthew J. Benskey · 2025 · Handbook of behavioral neuroscience
  32. Single‐Cell Transcriptomics Uncovers Cellular Heterogeneity, Mechanisms, and Therapeutic Targets for Ferroptosis‐Related Genes in Parkinson's Disease
    Meijun Liu, Min Yang, Keyun Guo, Si-Jia Zhu, Jie Yang · 2025 · European Journal of Neuroscience
  33. Intranigral injection of alpha-synuclein pre-formed fibrils leads to BBB compromise and bilateral dopaminergic neurodegeneration in A53T alpha-synuclein transgenic mice
    Soumitra Ghosh, Han Lin, Sarah Chu, Hai Ngu, Nanzhi Zang, Renee Raman, Kimberly L. Stark, Oded Foreman, Somaye Sadat Hashemifar, Amy E. Easton et al. · 2026 · Discover Neuroscience
  34. Decoding Neurodegeneration: Unveiling Cytokine Dynamics, Neuroinflammation, and the Role of Nanotherapeutic Approaches
    Harapriya Baral, Ravinder Kumar Kaundal · 2026 · Springer eBooks
  35. Potential Synergistic Roles of Ketogenic Diet and Stem Cell Therapy in Parkinson's Disease: A Narrative Review
    Princy Sindurakar, Vasavi Rakesh Gorantla, Dovenia S. Ponnoth · 2026 · Cureus
  36. Emerging use of bio-nanomaterials for brain pathologies
    Laiba Noor, Manu Smriti Singh, Arun K. Upadhyay, Vibhuti Joshi · 2026 · Nanotoxicology
  37. Interconnected roles of astrocytes and the blood–brain barrier in Parkinson’s disease: pathological evidence, mechanistic insights, and knowledge gaps
    Anna C. Stoll, Ashley S. Harms · 2026 · Frontiers in Aging Neuroscience
  38. Lorlatinib protects dopaminergic neurons by inhibiting ALK-mediated neuroinflammation in a mouse model of Parkinson’s disease
    Do-Yeon Kim, Seong-Eun Kim, Jung-Eun Park, Yea‐Hyun Leem, Jin‐Sun Park, Hee-Sun Kim · 2026 · Biomedicine & Pharmacotherapy
  39. The Role of Blood-Retinal Barrier in Retinal Neurodegenerative Diseases
    Lysander Blankenborg, Bela Anand‐Apte, Saptarshi Biswas · 2026 · American Journal Of Pathology
  40. Current modeling approaches for drug delivery to the central nervous system
    Shoaib A. Goraya, Abraham R. Tzafriri, Charles R.G. Guttmann, Farhad R. Nezami · 2026 · Therapeutic Delivery
  41. REPURPOSING DIABETES DRUGS FOR NEURODEGENERATIVE DISEASES: ANTI-DIABETIC DRUG REPOSITION
    Mrugank Parmar, Shital S. Panchal · 2019 · International Research Journal of Pharmacy
  42. Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
    Indrani Datta, Aishwarya Raj, Alka Kaushal · 2022 · Springer eBooks
  43. Role of Gut Brain and Gut Oral Axis in Progression of Parkinson’s Disease with Special Focus on Gut Microbes
    Ashwin Rajeev, Indranil Chattopadhyay · 2024 · Springer eBooks
  44. Neurodegenerative Disorder and Fine Particulate Matter
    Hironori Kawahara, Rikinari Hanayama · 2025 · Springer eBooks
  45. Brain microvascular endothelial cells differentiated from a Friedreich’s Ataxia patient iPSC are deficient in tight junction protein expression and paracellularly permeable
    Frances M. Smith, Daniel J. Kosman · 2025 · Frontiers in Molecular Neuroscience
  46. Gut and Parkinson’s disease
    Sujith Ovallath, Bahiya Sulthana · 2018 · Annals of Movement Disorders
  47. Advanced radiological investigation of levodopa- induced dyskinesia in Parkinson’s disease patients: assessment of blood brain barrier function
    Ophir Segal, Yael Mardor, Lior Orbach, Chen Hoffman, Sharon Hassin‐Baer · 2022 · Neurology Asia
  48. GLP-1 receptor agonists for Parkinson's disease
    Caroline A. Mulvaney, Gonçalo Silva Duarte, Suresh Menon, Joel D. Handley, Hedley C A Emsley · 2018 · Cochrane Database of Systematic Reviews
  49. Inflammation on the crossword of Parkinson’s disease and COVID-19
    Barnali Ray Basu, Randrita Pal · 2022 · Indian Journal of Clinical Anatomy and Physiology
  50. Commentary: “Age-Associated Physiological and Pathological Changes at the Blood-Brain Barrier: A Review”
    Franciska Erdö · 2017 · Clinical and Experimental Pharmacology
  51. miR126-mediated impaired vascular integrity in Rett syndrome
    Tatsuya Osaki, Zhengpeng Wan, Koji Haratani, Ylliah Jin, M. Campisi, D. Barbie, R. Kamm, M. Sur · 2024 · bioRxiv
  52. Pathophysiology of the Blood–Brain Barrier in Neuroinflammatory Diseases
    Petra Majerová, Andrej Kováč · 2017 · Springer eBooks
  53. Oxidative Stress and Redox Signalling in the Parkinson’s Disease Brain
    Pablo Hernández-Franco, Annandurai Anandhan, Rachel M. Foguth, Rodrigo Franco · 2017 · Royal Society of Chemistry eBooks
  54. Genetic Methods for Detecting Astrocytes, Neurons and Neurogenesis
    Natalia Nikolaevna Shusharina, Ekaterina Vladimirovna Silina, Aleksandr Alexandrovich Vasilyev, Irina Nikolaevna Dominova, Victor Aleksandrovich Stupin, Tatiana Georgievna Sinelnikova, Egor Borisovich Sotnikov, Andrei Turkin, Maksim Vladimirovich Patrushev · 2018 · Serbian Journal of Experimental and Clinical Research
  55. Experimental Studies of the Expression of Neurotransmitter Transporter Genes in Astrocytes in Different Part of the Brain
    Natalia Nikolaevna Shusharina, Maxim V. Patrushev, Ekaterina Vladimirovna Silina, Victor Aleksandrovich Stupin, Peter F. Litvitskiy, Aleksandra Sergeevna Orlova · 2019 · Neuroscience and Behavioral Physiology
  56. Multi-omics analysis of human brain tissue and an animal model of Parkinson’s Disease
    Lucas Caldi Gomes · 2020
  57. Blood–brain barrier targeted nanoparticles
    Magisetty Obulesu · 2020 · Elsevier eBooks
  58. Post-stroke dizziness of visual-vestibular cortices origin
    Nobuhiro Inoue, Satoshi Goto · 2020 · Journal of Neuroscience and Neurological Disorders
  59. Inflammatory Mediators Released by Brain Pericytes as Sensors and Effectors in Blood-Brain Barrier Dysfunction
    Shinya Dohgu, Fuyuko Takata, Yasufumi Kataoka · 2021 · Stem cell biology and regenerative medicine
  60. Evidence for Anti-inflammatory Effects and Modulation of Neurotransmitter Metabolism by Salvia Officinalis L.
    Gemma Margetts, Sotirios Kleidonas, Nawel S. Zaibi, Mohamed Sghaier Zaibi, Kieron D. Edwards · 2022 · Research Square
  61. Inhibition of Vascular Adhesion Protein 1 Protects Dopamine Neurons From the Effects of Acute Inflammation and Restores Habit Learning in the Striatum
    Serena Becchi, Alberto Buson, Bernard W. Balleine · 2021 · Research Square
  62. Aging reduces calreticulin expression and alters spontaneous calcium signals in astrocytic endfeet of the mouse dorsolateral striatum
    Rahul Srinivasan, Sara M. Zarate, Taylor E. Huntington, Pooneh Bagher · 2022 · Research Square
  63. The role of the Blood-Brain Barrier in cellular communication: A review
    Adline Fernando, Ashraf Kadar Shahib, Ragini Raghu, Mathangi Ganapathy · 2023 · World Journal of Biology Pharmacy and Health Sciences
  64. Caracterização do perfil astrocitário na substância negra de ratos com discinesia induzida por L-DOPA e tratados com doxiciclina
    Adrielle Ingrid de Oliveira Barbosa Santiago · 2022
  65. Merkezi Sinir Sisteminde MSS Mikroglia Mast Hücrelerinin Rolü ve Nörodejeneratif Hastalıklar Açısından Önemi
    Tansu KUŞAT, Emrah SUR · 2023
  66. Fibrinogen is the key factor associated with tremor relieve and recurrence in the ET patients subjected with unilateral MRgFUS thalamotomy
    Jiaji Lin, Haoxuan Lu, Dekang Zhang, Xianbing Bian, Jianxing Hu, Longsheng Pan, Xin Lou · 2024 · medRxiv
  67. Antiretroviral therapy and its cerebral vascular toxicity
    Harrison Rudd, Michal J. Toborek · 2024 · Elsevier eBooks
  68. Neurovascular mitochondrial susceptibility impacts blood-brain barrier function and behavior
    Alexis Mary Crockett, Hania Kébir, M. C. Vélez Colόn, Daniel Maxim Iascone, B. Cielieski, Adam J. Rossano, Amita Sehgal, Stewart A. Anderson, Jorge Ivan Alvarez · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Investigation and description of the New Brain and New Mind hypotheses
    Brandon Skylar Klinedinst · 2021
  70. Molecular Changes and Gut-Related Biomarkers in Parkinson’s Disease for Early Detection
    Sara A. Hashish, Amr M. Abdelhameed · 2024 · Springer eBooks
  71. Molecular Changes and Gut-Related Biomarkers in Parkinson’s Disease for Early Detection
    Sara A. Hashish, Amr M. Abdelhameed · 2024 · Springer eBooks
  72. Neurodegenerative diseases and dementia: the role of blood-brain barrier dysfunction (based on recent evidence)
    Oleg Semenovich Levin, З. К. Гехаева · 2025 · The Clinician
  73. The Effect of Dapagliflozin on Absence Epilepsy in WAG/Rij Rats
    Hatice Aygün · 2025 · Archives of Epilepsy
  74. Parkinson’s disease risk factors are expressed at brain barriers
    Floriane Bretheau, O.J. Arevalo, Vincent Gélinas, Louise Réveret, Océane Martinez, Marlie Ali Yandza, Bastien Jacquet, Léa Ferreira, Morgan Bérard, Charles Joly-Beauparlant et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Additional file 2 of Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
    Zhao, Zhe, Ning, Jingwen, 鲍秀琦, Shang, Meiyu, Ma, Jingwei, Gen Li, Zhang, Dan · 2021 · Figshare
  76. Additional file 1 of Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis
    Lifu Sheng, Stewart, Tessandra, Dishun Yang, Eric Thorland, David Soltys, Patrick Aro, Tarek Khrisat, Xie, Zhiying, Li, Na, Liu, Zongran et al. · 2020 · Figshare
  77. Additional file 4 of Evidence for anti-inflammatory effects and modulation of neurotransmitter metabolism by Salvia officinalis L.
    Gemma Margetts, Sotirios Kleidonas, Nawel S. Zaibi, Mohamed Sghaier Zaibi, Kieron D. Edwards · 2022 · Figshare
  78. Additional file 3 of Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
    Zhao, Zhe, Ning, Jingwen, 鲍秀琦, Shang, Meiyu, Ma, Jingwei, Gen Li, Zhang, Dan · 2021 · Figshare
  79. Additional file 4 of Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
    Zhao, Zhe, Ning, Jingwen, 鲍秀琦, Shang, Meiyu, Ma, Jingwei, Gen Li, Zhang, Dan · 2021 · Figshare
  80. Additional file 2 of High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease
    Osama F. Elabi, João Paulo Monteiro Carvalho Móri da Cunha, Abderahim Gaceb, Malin Fex, Gesine Paul · 2021 · Figshare
  81. Additional file 2 of Evidence for anti-inflammatory effects and modulation of neurotransmitter metabolism by Salvia officinalis L.
    Gemma Margetts, Sotirios Kleidonas, Nawel S. Zaibi, Mohamed Sghaier Zaibi, Kieron D. Edwards · 2022 · Figshare
  82. Additional file 5 of Evidence for anti-inflammatory effects and modulation of neurotransmitter metabolism by Salvia officinalis L.
    Gemma Margetts, Sotirios Kleidonas, Nawel S. Zaibi, Mohamed Sghaier Zaibi, Kieron D. Edwards · 2022 · Figshare
  83. Additional file 1 of High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease
    Osama F. Elabi, João Paulo Monteiro Carvalho Móri da Cunha, Abderahim Gaceb, Malin Fex, Gesine Paul · 2021 · Figshare
  84. Additional file 1 of Inhibition of vascular adhesion protein 1 protects dopamine neurons from the effects of acute inflammation and restores habit learning in the striatum
    Serena Becchi, Alberto Buson, Bernard W. Balleine · 2021 · Figshare
  85. Additional file 3 of High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease
    Osama F. Elabi, João Paulo Monteiro Carvalho Móri da Cunha, Abderahim Gaceb, Malin Fex, Gesine Paul · 2021 · Figshare
  86. Additional file 1 of Evidence for anti-inflammatory effects and modulation of neurotransmitter metabolism by Salvia officinalis L.
    Gemma Margetts, Sotirios Kleidonas, Zaibi, Nawel S., Mohamed Sghaier Zaibi, Kieron D. Edwards · 2022 · Figshare
  87. Additional file 3 of Evidence for anti-inflammatory effects and modulation of neurotransmitter metabolism by Salvia officinalis L.
    Gemma Margetts, Sotirios Kleidonas, Zaibi, Nawel S., Mohamed Sghaier Zaibi, Kieron D. Edwards · 2022 · Figshare
  88. Elucidating the Neuroinflammatory Modulatory Mechanisms of Maixuekang Capsule via Network Pharmacology in Cerebral Ischemia/Reperfusion Injury Rats
    Huihui Han, Jingmian Yang, Yuexia Ma, Xiumin Zhao, Changyu Gao, Xiangjian Zhang · 2026 · Developmental Neurobiology
  89. Blood-based biomarkers in Alzheimer’s and Parkinson’s disease: From molecular pathology to therapeutic potential
    Priya, Radhika Mittal, Jyotirmoy Banerjee, Aparna Banerjee Dixit · 2026 · International review of neurobiology
  90. Machine-Learning-Based Targeted Plasma Proteomic Analysis for Predicting Motor Progression in Parkinson’s Disease: An Interpretable Approach to Personalized Disease Management
    Wei Lin, Sanjeet Singh Grewal · 2026 · Bioengineering
  91. Striatal Dysregulation of Angpt2 and Circadian Gene Expression in a Rotenone Rat Model of Parkinson’s Disease
    Dalia Al Saeedy, Elisa Hawkins, Mikhail G. Dozmorov, Ohm S. Tripathi, Sina Mahdiani, Fay M. Jahr, Ola AlAzzeh, Laxmikant S. Deshpande, Joseph L. McClay · 2026 · Journal of Molecular Neuroscience
  92. Détection et caractérisation de l'α-synucléine dans le système nerveux entérique en conditions physiologiques et dans la maladie de Parkinson
    Anne-Gaëlle Corbillé · 2016 · theses.fr (ABES)
  93. Etude physiopathologique de la diffusion de la maladie de parkinson au système nerveux autonome
    Laurène Leclair‐Visonneau · 2017
  94. Understanding the role of perivascular macrophages in Parkinson's disease pathophysiology
    Jaime R. Fuentealba · 2017
  95. Interaction entre autophagie et exosomes au niveau synaptique dans la maladie de Parkinson
    Irene Sanchez-Mirasierra · 2023 · theses.fr (ABES)
  96. Engineered Exosomes: Innovative Strategies for Precision Drug Delivery in Parkinson’s Disease
    Xinyu Yuan, Cancan Wang, Jie Yan, Jinghan Wang, F Li, Yanqiu You, Zhongquan Qi · 2026 · Molecular Neurobiology
  97. Chorioretinal structural and microvascular alterations as biomarkers for the diagnosis of Parkinson's disease
    Alaa Din Abdin, Katharina Schwartz, Wissam Aljundi, Hakan Kaymak, Klaus C Fassbender, Vinzenz Fleischer, Nils Schröter, Gabriel González‐Escamilla, Klaus-Ulrich Dillmann, Sergiu Groppa et al. · 2026 · Parkinsonism & Related Disorders
  98. SU‐Eohyeol Pharmacopuncture Ameliorates Parkinson’s Disease–Associated Pain via the CB1 and PPARγ Pathways in an MPTP‐Induced Mouse Model
    Jung Im Kim, Heerim Yeo, Yousang Jo, Hyungjun Kim, Sang‐Min Park, No Soo Kim · 2026 · Pain Research and Management
  99. Glial cells in neurodegenerative diseases: a review
    Alif Hasan Pranto, Shahad Saif Khandker, Md Ekhtiar Uddin, Shamima Aktar, Sumaiya Islam Mumu, Rafiul Islam Khan, Nourin Khan Chowdhury, Jarukun Prekbunjun, Asifuzzaman Zisan, Rahima Begum · 2025 · Neurophysiology
  100. Probiotics and Plant Extracts in the Gut–Brain Axis: Mechanisms, Interactions, and Clinical Perspectives
    Zohreh Sattar, Javad Asili · 2026 · Probiotics and Antimicrobial Proteins